CAS number: 397864-44-7

General information about the Fluticasone Furoate active pharmaceutical ingredient

Fluticasone Furoate as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid with anti-inflammatory actions. Fluticasone Furoate API is used to treat seasonal and year-round allergy symptoms such as runny nose, itching, and sneezing. Fluticasone Furoate may also reduce other symptoms of seasonal allergies such as red, itchy, and watery eyes. Fluticasone Furoate can be used for maintenance treatment of asthma and/or chronic obstructive pulmonary disease (COPD). Fluticasone Furoate works by reducing swelling in nasal passages. Fluticasone Furoate can be administered as a nasal spray, suspension and powder. Fluticasone Furoate can be used in combination with β2-adrenergic agonist (LABA) for the treatment of COPD and asthma.

Axplora manufactures Fluticasone Furoate API

Fluticasone Furoate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Fluticasone Furoate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Fluticasone Furoate API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Fluticasone Furoate API.
  • Therapeutic area Respiratory
  • Monograph INTERNAL
  • Available grade Micronized
  • Regulatory documentation EU DMF
    CEP **
  • Produced in GRO